NovoCure Limited is an oncology company that develops and sells medical devices using tumor treating fields technology to address solid malignancies across multiple markets including North America, Europe, and Asia. The company's product portfolio encompasses several Optune devices designed for different applications, with additional research programs exploring effectiveness against various cancer types such as brain, gastric, liver, and pancreatic cancers. Founded in 2000 and based in Switzerland, the company manufactures and distributes these therapies internationally.
1Y: 16.72 (+28.6%) · range 10.03–19.99
entry readiness 37 · WEAK SETUP · exit proximity 0
Value area 14.89–18.51 · 48% of 120d volume overhead · moderate overhead
No source detections in the last 21 days.
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +8.03% | +11.59% | mature |
| 40d | -4.91% | +11.59% | 32/40d |